Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
tc
bio
biotech
boston blog main
crispr
enzymes
jennifer doudna
life sciences
acute myeloid leukemia
alx oncology
american biochemists
applied genetics
autoimmune diseases
berkeley
berkeley college of chemistry faculty
berkeley lights
bioethics
bioinnovation capital
biolabs
biology
biotech ipos
biotechnology
boston
boston top stories
cancer drugs
cancer immunotherapy
cd47
chemotherapy
chronic kidney disease
clinical trials
crispr therapeutics
crystallographers
daraprim
deals
deerfield healthcare technology acquisitions
deerfield management company
demo day tv
disrupt sf 2016
drama
drug pricing
What
biotech
5
×
industry
5
×
chemistry
companies
crispr
editing
gene
life
molecular
read
september
technology
accelerator
accelerator’s
agriculture
arrival
award
batch
berkeley
bernard
biology
bioremediation
bring
called
cas
cell
chat
coming
covering
day
days
demo
developed
discovery
disrupt
domino
doudna
driving
drug
effect
Language
unset
Current search:
biotech
×
industry
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@techcrunch.com
6 years ago
Tune in to IndieBio Accelerator’s Demo Day today
@techcrunch.com
7 years ago
CRISPR loses Nobel to tiny machines
@techcrunch.com
7 years ago
Jennifer Doudna, inventor of gene editing technology CRISPR Cas9, is coming to Disrupt
